Low-dose CT screening reduces lung cancer mortality and improves survival in broad populations
Prof Chris Marshall speaks with ecancer at the Wales Research and Diagnostic Positron Emission Tomography Imaging Centre (PETIC) in Cardiff, UK, to discuss the work conducted, the process of creating radio pharmaceuticals, and their application with PET scanning.
Prof Marshall discusses the products created at the facility and how they can be used to detect cancer.
Low-dose CT screening reduces lung cancer mortality and improves survival in broad populations
Boost IORT in breast cancer: Peruvian experience
Intraoperative radiotherapy for brain tumours
Predicting tumour mutations from pathology images may help increase personalised medicine utilisation
Choosing Wisely for young women with breast cancer: Radiotherapy
Whole body-MRI and fluorine 18 fluorodeoxyglucose PET/CT shows promising diagnostic accuracy in multiple myeloma patients
Best practice in HRRm testing in patients with metastatic prostate cancer
A combined PET-MRI scan could improve treatment for patients with early breast cancer
Hope vs Hype of evidence interpretation